SFA
LUCD icon

Sequoia Financial Advisors’s Lucid Diagnostics LUCD Stock Holding History

Sequoia Financial Advisors’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98.6K Buy
+92,150
New +$99.3K ﹤0.01% 2076

Other funds holding LUCD

TIA
Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Sequoia Financial Advisors's LUCD Position: Q2 2026 in Review

Sequoia Financial Advisors opened a new position in Lucid Diagnostics (LUCD) in Q2 2026: 92,150 shares worth $98.6K. The stake represents ﹤0.01% of the portfolio and ranks #2076 among its holdings.

8 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

  • Sequoia Financial Advisors held 92,150 shares of Lucid Diagnostics worth $98.6K as of Q2 2026.
  • Lucid Diagnostics was a new Sequoia Financial Advisors position in Q2 2026.
  • Lucid Diagnostics made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #2076 holding.
  • 8 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.